tiprankstipranks
Trending News
More News >

Bausch Health Signs New Board Agreements

Story Highlights
  • Bausch Health made agreements with key directors to resign if they engage in certain actions.
  • The company will support board nominees from these groups if no specified actions occur.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Bausch Health Signs New Board Agreements

Confident Investing Starts Here:

The latest announcement is out from Bausch Health Companies ( (TSE:BHC) ).

On May 20, 2025, Bausch Health Companies Inc. entered into letter agreements with Carl Icahn, John Paulson, and Sarah Kavanagh, who are overlapping directors on the boards of Bausch Health and Bausch + Lomb. These agreements stipulate that if any group engages in specified actions, they must resign from the boards. Additionally, the Icahn Group waived certain rights under a previous agreement. The agreements also ensure that, as long as no specified actions are taken, the company will support these groups’ nominees for board positions and allow them to join new board committees.

The most recent analyst rating on (TSE:BHC) stock is a Hold with a C$10.00 price target. To see the full list of analyst forecasts on Bausch Health Companies stock, see the TSE:BHC Stock Forecast page.

Spark’s Take on TSE:BHC Stock

According to Spark, TipRanks’ AI Analyst, TSE:BHC is a Neutral.

Bausch Health’s overall score reflects its solid revenue growth and cash flow generation capabilities, countered by high leverage and ongoing profitability issues. Technical indicators and valuation metrics are unfavorable, while recent earnings calls provide some optimism. Addressing financial stability and profitability concerns is crucial for long-term improvement.

To see Spark’s full report on TSE:BHC stock, click here.

More about Bausch Health Companies

Bausch Health Companies Inc. operates in the pharmaceutical industry, focusing on the development, manufacture, and marketing of a wide range of pharmaceutical products, primarily in the areas of eye health, gastroenterology, and dermatology.

Average Trading Volume: 388,264

Technical Sentiment Signal: Strong Sell

Current Market Cap: C$2.41B

For detailed information about BHC stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App